Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression. Paul M, Gope TK, Das P, Ain R, et al. BMC Cancer 2022;22:594.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Paul M, Gope TK, Das P, Ain R, et al. Nitric-Oxide Synthase trafficking inducer (NOSTRIN) is an emerging negative regulator of colon cancer progression. BMC Cancer 2022;22:594.
PMID: 35642021